|
1
|
Giuffrida R, Adamo L, Iannolo G, Vicari L,
Giuffrida D, Eramo A, Gulisano M, Memeo L and Conticello C:
Resistance of papillary thyroid cancer stem cells to chemotherapy.
Oncol Lett. 12:687–691. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parasuraman L, Kane SV, Pai PS and
Shanghvi K: Isolated metastasis in male breast from differentiated
thyroid carcinoma - oncological curiosity. A case report and review
of literature. Indian J Surg Oncol. 7:91–94. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shukla N, Osazuwa-Peters N and Megwalu UC:
Association between age and nodal metastasis in papillary thyroid
carcinoma. Otolaryngol Head Neck Surg. 165:43–49. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Podolski A, Castelluci E and Halmos B:
Precision medicine: BRAF mutations in thyroid cancer. Precis Cancer
Med. 2:292019. View Article : Google Scholar
|
|
5
|
Lloyd RV, Buehler D and Khanafshar E:
Papillary thyroid carcinoma variants. Head Neck Pathol. 5:51–56.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Worapongpaiboon R and Vongsaisuwon M:
Breast metastasis of papillary thyroid carcinoma. BMJ Case Rep.
15:e2510812022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ali SZ, Baloch ZW, Cochand-Priollet B,
Schmitt FC, Vielh P and VanderLaan PA: The 2023 Bethesda system for
reporting thyroid cytopathology. Thyroid. 33:1039–1044.
2023.PubMed/NCBI
|
|
8
|
Filetti S, Durante C, Hartl D, Leboulleux
S, Locati LD, Newbold K, Papotti MG and Berruti A; ESMO Guidelines
Committee. Electronic address, : simpleclinicalguidelines@esmo.org:
Thyroid cancer: ESMO clinical practice guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 30:1856–1833. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nair A, Devaraj A, Callister MEJ and
Bladwin DR: The Fleischner society 2017 and British thoracic
society 2015 guidelines for managing pulmonary nodules: Keep calm
and carry on. Thorax. 73:806–812. 2018. View Article : Google Scholar
|
|
10
|
Miao H, Verkooijen HM, Chia KS, Bouchardy
C, Pukkala E, Larønningen S, Mellemkjær L, Czene K and Hartman M:
Incidence and outcome of male breast cancer: An international
population-based study. J Clin Oncol. 29:4381–4386. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lautrup MD, Thorup SS, Jensen V, Bokmand
S, Haugaard K, Hoejris I, Jylling AB, Joernsgaard H, Lelkaitis G,
Oldenburg MH, et al: Male breast cancer: A nation-wide
population-based comparison with female breast cancer. Acta Oncol.
57:613–621. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Doyle S, Steel J and Porter G: Imaging
male breast cancer. Clin Radiol. 66:1079–1085. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khalkhali I and Cho J: Male breast cancer
imaging. Breast J. 21:217–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gadam S, Heller SL, Babb JS and Gao Y:
Male breast cancer risk assessment and screening recommendations in
high-risk men who undergo genetic counseling and multigene panel
testing. Clin Breast Cancer. 21:e74–e79. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Muir D, Kanthan R and Kanthan SC: Male
versus female breast cancers. A population-based comparative
immunohistochemical analysis. Arch Pathol Lab Med. 127:36–41. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bloom KJ, Govil H, Gattuso P, Reddy V and
Francescatti D: Status of HER-2 in male and female breast
carcinoma. Am J Surg. 182:389–392. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Colella R, Guerriero A, Giansanti M,
Sidoni A and Bellezza G: An additional case of breast tumor
resembling the tall cell variant of papillary thyroid carcinoma.
Int J Surg Pathol. 23:217–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tosi AL, Ragazzi M, Asioli S, Del Vecchio
M, Cavalieri M, Eusebi LH and Foschini MP: Breast tumor resembling
the tall cell variant of papillary thyroid carcinoma: Report of 4
cases with evidence of malignant potential. Int J Surg Pathol.
15:14–19. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eusebi V, Damiani S, Ellis IO, Azzopardi
JG and Rosai J: Breast tumor resembling the tall cell variant of
papillary thyroid carcinoma: Report of 5 cases. Am J Surg Pathol.
27:1114–1118. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pitino A, Squillaci S, Spairani C, Rassu
PC and Cosimi MF: Tall cell variant of papillary breast carcinoma:
An additional case with review of the literature. Pathologica.
109:162–167. 2017.PubMed/NCBI
|
|
21
|
Zhong J, Lei J, Jiang K, Li Z, Gong R and
Zhu J: Synchronous papillary thyroid carcinoma and breast ductal
carcinoma: A rare case report and literature review. Medicine
(Baltimore). 96:e61142017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kong H, Chen J and Tang SC: Synchronous
papillary thyroid carcinoma and breast ductal carcinoma. J Int Med
Res. 48:3000605209487102020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Raveendrannair AK, Mathews A, Varghese BT
and Jayasree K: Papillary carcinoma thyroid serving as recipient
tumor to carcinoma breast: A rare example of tumor-to-tumor
metastasis. Indian J Pathol Microbiol. 62:122–124. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kiziltan G, Bozdogan N and Ozaslan C:
Breast cancer metastasis into thyroid papillary carcinoma: A case
report. Breast J. 27:547–549. 2021. View Article : Google Scholar : PubMed/NCBI
|
